Doctolib selects Diginex Limited’s Plan A to turn their carbon management into strategic business value
Rhea-AI Summary
Diginex (NASDAQ: DGNX) announced that Doctolib has selected Plan A, Diginex’s AI-driven carbon accounting and decarbonization platform, to enable quarterly carbon reporting, strengthen B Corp credentials, and build a decarbonization roadmap linking CO₂ reduction to financial impact.
The collaboration provides a fully auditable system for investor-grade reporting, AI insights for ROI-positive climate actions, and support for emerging regulatory requirements.
Positive
- Enables quarterly carbon reporting for investor transparency
- Provides a fully auditable carbon accounting system
- Supports a decarbonization roadmap integrating CO₂ reductions with financial impact
- Deploys AI-driven insights to identify ROI-positive climate actions
- Strengthens Doctolib's B Corp positioning and regulatory readiness
Negative
- None.
News Market Reaction – DGNX
On the day this news was published, DGNX declined 2.24%, reflecting a moderate negative market reaction. Argus tracked a trough of -5.4% from its starting point during tracking. This price movement removed approximately $3M from the company's valuation, bringing the market cap to $128M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Consulting peers showed mixed, mostly modest moves: ICFI (-0.87%), CRAI (+0.26%), HURN (+0.25%), SBC (-2.23%), FCN (+1.47%). With DGNX down 4.87% pre-announcement, movements appear stock-specific rather than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 25 | Strategic deals sequence | Positive | +0.3% | Reseller alliance and sovereign finance alignment signaling ESG infrastructure focus. |
| Feb 24 | Sustainable finance pact | Positive | -2.3% | Signing Abu Dhabi Sustainable Finance Declaration to support emerging climate law reporting. |
| Feb 20 | Reseller partnership | Positive | -3.3% | Four-year Resulticks reseller agreement targeting US$40M revenue and payment restructure. |
| Feb 19 | Revenue alliance | Positive | +13.3% | Resulticks reseller deal with US$40M target and US$8M receivable restructuring. |
| Jan 28 | CEO transition | Positive | -17.8% | Appointment of Plan A founder as CEO, reinforcing integrated sustainability platform strategy. |
Recent strategic and partnership announcements have often been met with mixed to negative price reactions, even when fundamentals (revenue targets, acquisitions, governance steps) appeared constructive.
Over the last few months, Diginex reported several platform-building moves. It signed multiple Resulticks agreements targeting US$40 million cumulative revenue and restructuring an US$8 million funding arrangement. It aligned with the Abu Dhabi sustainable finance ecosystem and highlighted a CEO transition toward carbon accounting and decarbonization expertise. The company also emphasized integration of Plan A and broader sustainability infrastructure. Today’s Doctolib–Plan A collaboration extends that strategy by showcasing Plan A’s adoption with a leading European healthcare platform, reinforcing earlier positioning around enterprise and sovereign sustainability solutions.
Market Pulse Summary
This announcement highlights Plan A’s integration into Doctolib’s carbon reporting, reinforcing Diginex’s focus on investor-grade sustainability infrastructure. It showcases practical use cases—quarterly carbon reporting, B Corp alignment, and ROI-linked decarbonization planning—following earlier acquisitions and reseller alliances. Investors may track client traction for Plan A, revenue progress against the US$40 million Resulticks target, and ongoing operating losses of $(5,212,879) as key indicators of how quickly this strategy converts into durable financial performance.
Key Terms
carbon accounting medical
decarbonization medical
b corp regulatory
AI-generated analysis. Not financial advice.
Leading European healthcare platform deploys AI-driven carbon accounting solution to meet investor expectations and strengthen B Corp positioning
PARIS and LONDON, March 19, 2026 (GLOBE NEWSWIRE) -- Diginex Limited (NASDAQ: DGNX) today announced that Doctolib SAS, Europe's leading healthcare technology company, entered into a strategic relationship with Plan A, Europe’s leading provider of corporate carbon accounting and decarbonization software. The collaboration will enable Doctolib to transition to quarterly carbon reporting, strengthen its B Corp credentials, and build a forward-looking decarbonization roadmap that integrates CO₂ reduction with financial impact analysis.
As investor and regulatory expectations around climate transparency intensify, Doctolib is deploying Plan A's platform for a reliable and fully auditable system. The solution will support Doctolib's reporting to investors while future-proofing the business for emerging regulatory requirements transforming Carbon Management into Strategic business value.
By leveraging Plan A's AI-driven insights and expert support, Doctolib will establish and implement ROI-positive climate actions.
Pierre Delpy, Financial Control Director, Doctolib: "This collaboration with Plan A gives us a stronger, more reliable, and auditable view of our carbon footprint. With clearer data, we can align teams around a single source of truth and use scenarios to quantify the real impact of specific actions, including their costs and benefits. This clarity enables us to prioritise the initiatives with the highest emissions-reduction potential, while staying aligned with our B Corp commitments and adapting to evolving regulations."
Lubomila Jordanova, CEO Plan A & Diginex, added: "We are proud to work with Doctolib, a company exemplifying exactly what climate leadership looks like in practice: shedding light on the topic of decarbonisation within the organisation to engage teams to turn insights into concrete actions. By deploying Plan A's platform, they are building the carbon intelligence infrastructure that supports stronger RFP performance, and investor-grade reporting. This is the model we want to see every forward-thinking business adopt."
About Doctolib
Since 2013, Doctolib has been supporting 500,000 health professionals and 90 million patients across Europe. We build technology that improves the daily life of health professionals and gives them more time to fully focus on their patients. Our Operating System for health professionals brings together appointment scheduling, digital secretariat, secure professional messaging, electronic health records, financial solutions, and AI assistants dedicated to clinical or administrative tasks. Doctolib is also a health companion that unifies prevention, guidance, and access to care in one place. It helps people find the right professional faster, better understand their health, and benefit from more personalized and continuous support. With 3,000 employees across more than 30 cities, Doctolib works every day alongside health professionals to build, together, the future of healthcare through trusted technology and high medical standards. (www.doctolib.com)
For more information, please visit the Company’s website: www.doctolib.com.
About Plan A
Plan A, a Diginex company, is Europe’s leading provider of corporate carbon accounting and decarbonization software. Certified by TÜV Rheinland and B Corp, its AI powered platform helps thousands of businesses automate emissions management and create measurable business value.
For more information, please visit the Company’s website: www.plana.earth.
About Diginex
Diginex Limited (Nasdaq: DGNX; ISIN KYG286871044), headquartered in London, is a sustainable RegTech business that empowers businesses and governments to streamline ESG, climate, and supply chain data collection and reporting. The Company utilizes blockchain, AI, machine learning and data analysis technology to lead change and increase transparency in corporate regulatory reporting and sustainable finance. Diginex’s products and services solutions enable companies to collect, evaluate and share sustainability data through easy-to-use software.
For more information, please visit the Company’s website: https://www.diginex.com/.
Forward‑Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law.
Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results disclosed in the Company's filings with the SEC.
Contacts: Diginex
Investor Relations
Email: ir@diginex.com
IR Contact - Europe
Anna Höffken
Phone: +49.40.609186.0
Email: diginex@kirchhoff.de
IR Contact - US
Jackson Lin
Lambert by LLYC
Phone: +1 (646) 717-4593
Email: jian.lin@llyc.global
Doctolib: presse@doctolib.com
FAQ
What did Diginex announce about Doctolib and Plan A on March 19, 2026 (DGNX)?
How will Plan A change Doctolib's carbon reporting cadence and quality (DGNX)?
What investor benefits does Doctolib gain by using Plan A via Diginex (DGNX)?
Does Plan A promise financial impact analysis for Doctolib's decarbonization (DGNX)?
Will deploying Plan A affect Doctolib's B Corp commitments and regulatory readiness (DGNX)?
